Finance

Lists
AVY:NYSE
Avery Dennison Corp
$187.06
-1.39%
(-2.64) 1D
Nov 6, 11:21:48 AM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AVY...
Open
$185.48
High
$187.74
Low
$185.00
Mkt. cap
14.13B
Avg. vol.
683.46K
Volume
137.28K
Dividend
2.14%
Quarterly dividend
$1.00
Ex-dividend date
Sep 2, 2026
P/E ratio
20.24
52-wk high
$199.54
52-wk low
$152.42
EPS
$9.24
Beta
0.78
Shares outstanding
75.51M
No. of employees
35K
Open
$185.48
High
$187.74
Low
$185.00
Mkt. cap
14.13B
Avg. vol.
683.46K
Volume
137.28K
Dividend
2.14%
Quarterly dividend
$1.00
Ex-dividend date
Sep 2, 2026
P/E ratio
20.24
52-wk high
$199.54
52-wk low
$152.42
EPS
$9.24
Beta
0.78
Shares outstanding
75.51M
No. of employees
35K
News stories
From web sources and news partners
Profile
Avery Dennison Corporation is an American multinational manufacturer and distributor of pressure-sensitive adhesive materials, apparel branding labels and tags, RFID inlays, and specialty medical products. The company is a member of the Fortune 500 and is headquartered in Mentor, Ohio. Wikipedia
About Avery Dennison Corp
CEODeon Stander
Employees35K
Founded1935
Headquarters-
SectorMaterials
IndustryMaterial
Websiteaverydennison.com
Analyst ratings
Based on 9 analysts giving stock ratings to AVY in the past 3 months
Strong buy
Buy
7
Hold
2
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for AVY in the last 3 months.
Highest
Current $187.06
$230.00 (+22.96%)
Average
$201.38 (+7.66%)
Lowest
$181.00 (-3.24%)
Analyst
Recommendation
Action
Price target
Projected
Date
Anthony Pettinari
Citi
Hold
Maintained
$191.00
+2.1%
11/02/2026
Jeffrey Zekauskas
J.P. Morgan
Buy
Reiterated
$200.00
+6.9%
10/30/2026
Matt Roberts
Raymond James
Buy
Maintained
$198.00
+5.8%
10/30/2026
Joshua Spector
UBS
Buy
Reiterated
$230.00
+23%
10/30/2026
John McNulty
BMO Capital
Buy
Maintained
$213.00
+13.9%
10/29/2026
Michael Roxland
Truist Financial
Buy
Maintained
$208.00
+11.2%
10/12/2026
George Staphos
Bank of America Securities
Buy
Maintained
$190.00
+1.6%
10/05/2026
Ghansham Panjabi
Robert W. Baird
Buy
Reiterated
-
-
09/24/2026
Unknown Analyst
Jefferies
Hold
Maintained
$181.00
-3.2%
09/17/2026
Alexandra Yates
Argus Research
Buy
Maintained
$175.00
-6.4%
06/03/2026
Hillary Cacanando
Deutsche Bank
Buy
Initiated
$200.00
+6.9%
03/31/2026
John Dunigan
Jefferies
Hold
Maintained
$185.00
-1.1%
03/10/2026
Last report
Oct 29, 2026
Fiscal period
Q3 2026
$2.42 / $2.32
+4.12%beat
Revenue / Est. (USD)
2.33B / 2.26B
+3.02%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
2.27B
2.30B
2.46B
2.33B
Cost of goods sold
1.62B
1.63B
1.73B
1.68B
Cost of revenue
1.62B
1.63B
1.73B
1.68B
Research and development expenses
136.60M
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
225.50M
375.10M
394.80M
372.70M
Operating expense
362.10M
375.10M
394.80M
372.70M
Total operating expenses
1.98B
2.01B
2.13B
2.05B
Operating income
288.60M
289.70M
334.60M
282.10M
Other non operating income
-8.20M
3.90M
5.10M
4.40M
EBT including unusual items
207.80M
240.40M
282.70M
241.20M
EBT excluding unusual items
243.90M
257.50M
303.00M
250.30M
Income tax expense
41.40M
72.30M
78.60M
71.50M
Effective tax rate
19.92%
30.07%
27.80%
29.64%
Other operating expenses
-
-
-
-
Net income
166.40M
168.10M
204.10M
169.70M
Net profit margin
7.33%
7.31%
8.29%
7.28%
Earnings per share
2.45
2.47
2.89
2.42
Interest and investment income
-
-
-
-
Interest expense
-37.20M
-35.60M
-35.90M
-35.70M
Net interest expenses
-37.20M
-35.60M
-35.90M
-35.70M
Depreciation and amortization charges
-
-
-
-
EBITDA
333.90M
376.50M
421.00M
367.70M
Gain or loss from assets sale
-1.40M
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps